{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T22:36:54Z","timestamp":1775687814566,"version":"3.50.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,5,30]],"date-time":"2016-05-30T00:00:00Z","timestamp":1464566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00105-016-3804-4","type":"journal-article","created":{"date-parts":[[2016,5,30]],"date-time":"2016-05-30T14:01:38Z","timestamp":1464616898000},"page":"445-453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Pustul\u00f6se Psoriasis","Pustular psoriasis"],"prefix":"10.1007","volume":"67","author":[{"given":"P.","family":"Weisenseel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Wilsmann-Theis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Reich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"M\u00f6ssner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,30]]},"reference":[{"key":"3804_CR1","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1038\/jid.2013.361","volume":"133","author":"F Capon","year":"2013","unstructured":"Capon F (2013) IL36RN mutations in generalized pustular psoriasis: just the tip of the iceberg? J\u00a0Invest Dermatol 133:2503\u20132504","journal-title":"J Invest Dermatol"},{"issue":"11","key":"3804_CR2","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1038\/jid.2013.214","volume":"133","author":"A Korber","year":"2013","unstructured":"Korber A, Mossner R, Renner R et\u00a0al (2013) Mutations in IL36RN in patients with generalized pustular psoriasis. J\u00a0Invest Dermatol 133(11):2634\u20132637","journal-title":"J Invest Dermatol"},{"key":"3804_CR3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi S, Guigue P, Renshaw BR et al (2011) Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 365:620\u2013628","journal-title":"N Engl J Med"},{"key":"3804_CR4","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1038\/jid.2015.288","volume":"135","author":"DM Berki","year":"2015","unstructured":"Berki DM, Liu L, Choon SE et\u00a0al (2015) Activating CARD14 mutations are associated with generalized pustular psoriasis but rarely account for familial recurrence in psoriasis Vulgaris. J\u00a0Invest Dermatol 135:2964\u20132970","journal-title":"J Invest Dermatol"},{"key":"3804_CR5","doi-asserted-by":"crossref","unstructured":"Brenner M, Molin S, Ruebsam K, Weisenseel P, Ruzicka T, Prinz JC (2009) Generalized pustular psoriasis induced by systemic glucocorticosteroids: four cases and recommendations for treatment. Br J Dermatol 161:964\u2013966","DOI":"10.1111\/j.1365-2133.2009.09348.x"},{"key":"3804_CR6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00393-012-1127-0","volume":"72","author":"P Weisenseel","year":"2013","unstructured":"Weisenseel P, Reich K (2013) Paradoxical skin reactions under therapy with TNF-alpha antagonists. Z\u00a0Rheumatol 72:423\u2013428","journal-title":"Z Rheumatol"},{"key":"3804_CR7","doi-asserted-by":"crossref","unstructured":"Robinson A, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Bebo BF, Jr., Kalb RE (2012) Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 67:279-288 (2012)","DOI":"10.1016\/j.jaad.2011.01.032"},{"key":"3804_CR8","author":"S Imafuku","year":"2016","unstructured":"Imafuku S, Honma M, Okubo Y et al (2016) Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52-week analysis from phase\u00a0III open-label multicenter Japanese study. J Dermatol : doi:\/10.1111\/1346-8138.13306","journal-title":"J Dermatol"},{"key":"3804_CR9","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/jdv.12773","volume":"29","author":"H Saeki","year":"2015","unstructured":"Saeki H, Nakagawa H, Ishii T et al (2015) Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis. J Eur Acad Dermatol Venereol 29:1148\u20131155","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3804_CR10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/1744-9987.12342","volume":"19","author":"T Fujisawa","year":"2015","unstructured":"Fujisawa T, Suzuki S, Mizutani Y et\u00a0al (2015) Granulocyte and monocyte adsorption Apheresis for generalized pustular psoriasis: therapeutic outcomes in three refractory patients. Ther Apher Dial 19:336\u2013341","journal-title":"Ther Apher Dial"},{"key":"3804_CR11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/bjd.12548","volume":"170","author":"U Huffmeier","year":"2014","unstructured":"Huffmeier U, Watzold M, Mohr J et\u00a0al (2014) Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations. Br J\u00a0Dermatol 170:202\u2013204","journal-title":"Br J Dermatol"},{"key":"3804_CR12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000346578","volume":"226","author":"QQ Gao","year":"2013","unstructured":"Gao QQ, Xi MR, Yao Q (2013) Impetigo Herpetiformis during pregnancy: a case report and literature review. Dermatology 226:35\u201340","journal-title":"Dermatology"},{"key":"3804_CR13","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1038\/jid.2014.177","volume":"134","author":"K Sugiura","year":"2014","unstructured":"Sugiura K, Oiso N, Iinuma S et\u00a0al (2014) IL36RN mutations underlie impetigo herpetiformis. J\u00a0Invest Dermatol 134:2472\u20132474","journal-title":"J Invest Dermatol"},{"key":"3804_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1525-1470.2002.00026.x","volume":"19","author":"PB Liao","year":"2002","unstructured":"Liao PB, Rubinson R, Howard R et\u00a0al (2002) Annular pustular psoriasis\u2013most common form of pustular psoriasis in children: report of three cases and review of the literature. Pediatr Dermatol 19:19\u201325","journal-title":"Pediatr Dermatol"},{"key":"3804_CR15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00105-007-1316-y","volume":"58","author":"A Albert","year":"2007","unstructured":"Albert A, Hein R, Ring J et al (2007) Erythema annulare centrifugum-like psoriasis cum pustulatione. Hautarzt 58:769\u2013773","journal-title":"Hautarzt"},{"key":"3804_CR16","first-page":"564","volume":"32","author":"R Stadler","year":"1981","unstructured":"Stadler R, Orfanos CE (1981) Erythema anulare centrifugum with pustulation. Successful oral retinoid therapy. Hautarzt 32:564\u2013566","journal-title":"Hautarzt"},{"key":"3804_CR17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1468-3083.2003.00715.x","volume":"17","author":"E Vocks","year":"2003","unstructured":"Vocks E, Worret WI, Ring J (2003) Erythema annulare centrifugum-type psoriasis: a particular variant of acute-eruptive psoriasis. J Eur Acad Dermatol Venereol 17:446\u2013448","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3804_CR18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5021\/ad.2012.24.2.233","volume":"24","author":"SA Lo","year":"2012","unstructured":"Lo SA, Brancaccio G, Puca RV et\u00a0al (2012) Etanercept in the treatment of generalized annular pustular psoriasis. Ann Dermatol 24:233\u2013234","journal-title":"Ann Dermatol"},{"key":"3804_CR19","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ajhg.2014.04.005","volume":"94","author":"N Setta-Kaffetzi","year":"2014","unstructured":"Setta-Kaffetzi N, Simpson MA, Navarini AA et al (2014) AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking. Am J Hum Genet 94:790\u2013797","journal-title":"Am J Hum Genet"},{"key":"3804_CR20","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1365-2133.2004.05992.x","volume":"150","author":"D Wilsmann-Theis","year":"2004","unstructured":"Wilsmann-Theis D, Hagemann T, Dederer H et al (2004) Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1\u202f% ointment. Br J Dermatol 150:1194\u20131197","journal-title":"Br J Dermatol"},{"key":"3804_CR21","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1365-4632.2011.04993.x","volume":"50","author":"VN Sehgal","year":"2011","unstructured":"Sehgal VN, Verma P, Sharma S et\u00a0al (2011) Acrodermatitis continua of Hallopeau: evolution of treatment options. Int J Dermatol 50:1195\u20131211","journal-title":"Int J Dermatol"},{"key":"3804_CR22","first-page":"221","volume":"44","author":"M Bacharach-Buhles","year":"1993","unstructured":"Bacharach-Buhles M, el-Gammal S, Altmeyer P (1993) The pustular bacterid (Andrews). Are there clinical criteria for differentiating from psoriasis pustulosa palmaris et plantaris? Hautarzt 44:221\u2013224","journal-title":"Hautarzt"},{"key":"3804_CR23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2133.1985.tb02046.x","volume":"113","author":"SM Burge","year":"1985","unstructured":"Burge SM, Ryan TJ (1985) Acute palmoplantar pustulosis. Br J Dermatol 113:77\u201383","journal-title":"Br J Dermatol"},{"key":"3804_CR24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2340\/0001555551284288","volume":"51","author":"L Hellgren","year":"1971","unstructured":"Hellgren L, Mobacken H (1971) Pustulosis palmaris et plantaris. Prevalence, clinical observations and prognosis. Acta Derm Venereol 51:284\u2013288","journal-title":"Acta Derm Venereol"},{"key":"3804_CR25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/bmj.291.6499.861","volume":"291","author":"CJ O\u2019Doherty","year":"1985","unstructured":"O\u2019Doherty CJ, MacIntyre C (1985) Palmoplantar pustulosis and smoking. Br Med J (Clin Res Ed) 291:861\u2013864","journal-title":"Br Med J (Clin Res Ed)"},{"key":"3804_CR26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2340\/0001555551289294","volume":"51","author":"W Enfors","year":"1971","unstructured":"Enfors W, Molin L (1971) Pustulosis palmaris et plantaris. A follow-up study of a ten-year material. Acta Derm Venereol 51:289\u2013294","journal-title":"Acta Derm Venereol"},{"key":"3804_CR27","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1111\/jdv.12545","volume":"29","author":"G Becher","year":"2015","unstructured":"Becher G, Jamieson L, Leman J (2015) Palmoplantar pustulosis\u2013a retrospective review of comorbid conditions. J\u00a0Eur Acad Dermatol Venereol 29:1854\u20131856","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3804_CR28","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/bjd.12223","volume":"168","author":"AM Brunasso","year":"2013","unstructured":"Brunasso AM, Puntoni M, Aberer W et\u00a0al (2013) Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study. Br\u00a0J\u00a0Dermatol 168:1243\u20131251","journal-title":"Br J Dermatol"},{"key":"3804_CR29","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaad.2008.11.910","volume":"60","author":"E Farley","year":"2009","unstructured":"Farley E, Masrour S, McKey J et al (2009) Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool. J Am Acad Dermatol 60:1024\u20131031","journal-title":"J Am Acad Dermatol"},{"key":"3804_CR30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2133.2006.07725.x","volume":"156","author":"G Michaelsson","year":"2007","unstructured":"Michaelsson G, Kristjansson G, Pihl LI et al (2007) Palmoplantar pustulosis and gluten sensitivity: a study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten-free diet. Br J Dermatol 156:659\u2013666","journal-title":"Br J Dermatol"},{"key":"3804_CR31","first-page":"109","volume":"6","author":"CL Benhamou","year":"1988","unstructured":"Benhamou CL, Chamot AM, Kahn MF (1988) Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol 6:109\u2013112","journal-title":"Clin Exp Rheumatol"},{"key":"3804_CR32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.semarthrit.2012.05.006","volume":"42","author":"MT Nguyen","year":"2012","unstructured":"Nguyen MT, Borchers A, Selmi C et\u00a0al (2012) The SAPHO syndrome. Semin Arthritis Rheum 42:254\u2013265","journal-title":"Semin Arthritis Rheum"},{"key":"3804_CR33","first-page":"89","volume":"72","author":"T Yamamoto","year":"2011","unstructured":"Yamamoto T (2011) Triggering role of focal infection in the induction of extra-palmoplantar lesions and pustulotic arthro-osteitis associated with palmoplantar pustulosis. Adv Otorhinolaryngol 72:89\u201392","journal-title":"Adv Otorhinolaryngol"},{"key":"3804_CR34","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1365-2133.2007.07908.x","volume":"156","author":"P Weisenseel","year":"2007","unstructured":"Weisenseel P, Kuznetsov AV, Ruzicka T et\u00a0al (2007) Palmoplantar pustulosis is not inevitably associated with antigliadin antibodies. Br J Dermatol 156:1399\u20131400","journal-title":"Br J Dermatol"},{"key":"3804_CR35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2133.1989.tb15516.x","volume":"121","author":"T Agner","year":"1989","unstructured":"Agner T, Sindrup JH, Hoier-Madsen M et al (1989) Thyroid disease in pustulosis palmoplantaris. Br J Dermatol 121:487\u2013491","journal-title":"Br J Dermatol"},{"key":"3804_CR36","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1365-2133.1998.02113.x","volume":"138","author":"MO Eriksson","year":"1998","unstructured":"Eriksson MO, Hagforsen E, Lundin IP et\u00a0al (1998) Palmoplantar pustulosis: a clinical and immunohistological study. Br J Dermatol 138:390\u2013398","journal-title":"Br J Dermatol"},{"key":"3804_CR37","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1038\/jid.2010.87","volume":"130","author":"M Murakami","year":"2010","unstructured":"Murakami M, Ohtake T, Horibe Y et\u00a0al (2010) Acrosyringium is the main site of the vesicle\/pustule formation in palmoplantar pustulosis. J\u00a0Invest Dermatol 130:2010\u20132016","journal-title":"J Invest Dermatol"},{"key":"3804_CR38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archderm.1974.01630040028005","volume":"109","author":"M Uehara","year":"1974","unstructured":"Uehara M, Ofuji S (1974) The morphogenesis of pustulosis palmaris et plantaris. Arch Dermatol 109:518\u2013520","journal-title":"Arch Dermatol"},{"key":"3804_CR39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1600-0625.2011.01325.x","volume":"20","author":"M Murakami","year":"2011","unstructured":"Murakami M, Hagforsen E, Morhenn V et al (2011) Patients with palmoplantar pustulosis have increased\u00a0IL-17 and IL-22 levels both in the lesion and serum. Exp Dermatol 20:845\u2013847","journal-title":"Exp Dermatol"},{"key":"3804_CR40","doi-asserted-by":"crossref","first-page":"e110677","DOI":"10.1371\/journal.pone.0110677","volume":"9","author":"M Murakami","year":"2014","unstructured":"Murakami M, Kaneko T, Nakatsuji T et al (2014) Vesicular\u00a0LL-37 contributes to inflammation of the lesional skin of palmoplantar pustulosis. PLoS ONE 9:e110677","journal-title":"PLoS ONE"},{"key":"3804_CR41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2133.2002.04640.x","volume":"146","author":"E Hagforsen","year":"2002","unstructured":"Hagforsen E, Edvinsson M, Nordlind K et\u00a0al (2002) Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis. Br J Dermatol 146:383\u2013391","journal-title":"Br J Dermatol"},{"key":"3804_CR42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2249.2009.03945.x","volume":"157","author":"T Yoshizaki","year":"2009","unstructured":"Yoshizaki T, Bandoh N, Ueda S et al (2009) Up-regulation of CC chemokine receptor 6 on tonsillar T cells and its induction by in vitro stimulation with alpha-streptococci in patients with pustulosis palmaris et plantaris. Clin Exp Immunol 157:71\u201382","journal-title":"Clin Exp Immunol"},{"key":"3804_CR43","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s10875-010-9451-0","volume":"30","author":"S Ueda","year":"2010","unstructured":"Ueda S, Takahara M, Tohtani T et al (2010) Up-regulation of ss1 integrin on tonsillar T cells and its induction by in vitro stimulation with alpha-streptococci in patients with pustulosis Palmaris et Plantaris. J Clin Immunol 30:861\u2013871","journal-title":"J Clin Immunol"},{"key":"3804_CR44","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1523-1747.2003.12094.x","volume":"120","author":"K Asumalahti","year":"2003","unstructured":"Asumalahti K, Ameen M, Suomela S et\u00a0al (2003) Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J\u00a0Invest Dermatol 120:627\u2013632","journal-title":"J Invest Dermatol"},{"key":"3804_CR45","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/jid.2012.490","volume":"133","author":"N Setta-Kaffetzi","year":"2013","unstructured":"Setta-Kaffetzi N, Navarini AA, Patel VM et al (2013) Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes. J Invest Dermatol 133:1366\u20131369","journal-title":"J Invest Dermatol"},{"key":"3804_CR46","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1038\/jid.2015.186","volume":"135","author":"R Mossner","year":"2015","unstructured":"Mossner R, Frambach Y, Wilsmann-Theis D et al (2015) Palmoplantar pustular psoriasis is associated with Missense variants in CARD14, but not with loss-of-function mutations in IL36RN in european patients. J Invest Dermatol 135:2538\u20132541","journal-title":"J Invest Dermatol"},{"key":"3804_CR47","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1365-2133.2006.07731.x","volume":"156","author":"K Kingo","year":"2007","unstructured":"Kingo K, Mossner R, Koks S et\u00a0al (2007) Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis. Br J Dermatol 156:646\u2013652","journal-title":"Br J Dermatol"},{"key":"3804_CR48","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3109\/09546634.2013.848258","volume":"25","author":"W Wu","year":"2014","unstructured":"Wu W, Debbaneh M, Moslehi H et\u00a0al (2014) Tonsillectomy as a treatment for psoriasis: a review. J\u00a0Dermatolog Treat 25:482\u2013486","journal-title":"J Dermatolog Treat"},{"key":"3804_CR49","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2340\/0001555571540542","volume":"71","author":"K Kragballe","year":"1991","unstructured":"Kragballe K, Larsen FG (1991) A hydrocolloid occlusive dressing plus triamcinolone acetonide cream is superior to clobetasol cream in palmo-plantar pustulosis. Acta Derm Venereol 71:540\u2013542","journal-title":"Acta Derm Venereol"},{"key":"3804_CR50","first-page":"3","volume":"6","author":"AM Marsland","year":"2001","unstructured":"Marsland AM, Griffiths CE (2001) Treatments for chronic palmoplantar pustular psoriasis. Skin Therapy Lett 6:3\u20135","journal-title":"Skin Therapy Lett"},{"key":"3804_CR51","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/1346-8138.13064","volume":"43","author":"Y Umezawa","year":"2015","unstructured":"Umezawa Y, Nakagawa H, Tamaki K (2015) Phase\u00a0III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: A randomized, double-blind, placebo-controlled trial. J Dermatol 43:288","journal-title":"J Dermatol"},{"key":"3804_CR52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/09546634.2015.1052036","volume":"27","author":"M Muro","year":"2015","unstructured":"Muro M, Kawakami H, Matsumoto Y et al (2015) Topical combination therapy with vitamin D and corticosteroid ointment for palmoplantar pustulosis: A prospective, randomized, left-right comparison study. J Dermatolog Treat 27:51","journal-title":"J Dermatolog Treat"},{"issue":"Suppl 5","key":"3804_CR53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jdv.12561","volume":"28","author":"M Sevrain","year":"2014","unstructured":"Sevrain M, Richard MA, Barnetche T et al (2014) Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion. J Eur Acad Dermatol Venereol 28(Suppl 5):13\u201316","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3804_CR54","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2133.1991.tb04955.x","volume":"124","author":"AM Layton","year":"1991","unstructured":"Layton AM, Sheehan-Dare R, Cunliffe WJ (1991) A double-blind, placebo-controlled trial of topical PUVA in persistent palmoplantar pustulosis. Br J Dermatol 124:581\u2013584","journal-title":"Br J Dermatol"},{"key":"3804_CR55","author":"AM Marsland","year":"2006","unstructured":"Marsland AM, Chalmers RJ, Hollis S et\u00a0al (2006) Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev CD001433: doi:\/10.1002\/14651858.cd001433.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"3804_CR56","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2133.1988.tb03499.x","volume":"119","author":"A Lassus","year":"1988","unstructured":"Lassus A, Geiger JM (1988) Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial. Br J Dermatol 119:755\u2013759","journal-title":"Br J Dermatol"},{"key":"3804_CR57","doi-asserted-by":"crossref","unstructured":"Wilken R, Sharma A, Patel F et\u00a0al (2015) Successful treatment of palmoplantar pustulosis with isotretinoin. Dermatol Online J 21","DOI":"10.5070\/D3218028439"},{"key":"3804_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14401","author":"K Reich","year":"2016","unstructured":"Reich K, Graff O, Mehta N (2016) Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomised Phase\u00a0II study. Br J Dermatol : doi:10.1111\/bjd.14401","journal-title":"Br J Dermatol"},{"key":"3804_CR59","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1365-2133.2012.11063.x","volume":"167","author":"N Irla","year":"2012","unstructured":"Irla N, Navarini AA, Yawalkar N (2012) Alitretinoin abrogates innate inflammation in palmoplantar pustular psoriasis. Br J Dermatol 167:1170\u20131174","journal-title":"Br J Dermatol"},{"key":"3804_CR60","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-3083.2009.03197.x","volume":"23","author":"E Adisen","year":"2009","unstructured":"Adisen E, Tekin O, Gulekon A et\u00a0al (2009) A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients. J\u00a0Eur Acad Dermatol Venereol 23:814\u2013819","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3804_CR61","first-page":"153","volume":"94","author":"CW Stanford","year":"2014","unstructured":"Stanford CW, Kollipara R, Melookaran AM et al (2014) Palmoplantar pustular psoriasis following initiation of a beta-blocker: disease control with low-dose methotrexate. Cutis 94:153\u2013155","journal-title":"Cutis"},{"key":"3804_CR62","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/archderm.1993.01680310043006","volume":"129","author":"S Reitamo","year":"1993","unstructured":"Reitamo S, Erkko P, Remitz A et al (1993) Cyclosporine in the treatment of palmoplantar pustulosis. A randomized, double-blind, placebo-controlled study. Arch Dermatol 129:1273\u20131279","journal-title":"Arch Dermatol"},{"key":"3804_CR63","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1046\/j.1365-2133.1998.02555.x","volume":"139","author":"P Erkko","year":"1998","unstructured":"Erkko P, Granlund H, Remitz A et al (1998) Double-blind placebo-controlled study of long-term low-dose cyclosporin in the treatment of palmoplantar pustulosis. Br J Dermatol 139:997\u20131004","journal-title":"Br J Dermatol"},{"key":"3804_CR64","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1365-2133.2003.05424.x","volume":"149","author":"H Stander","year":"2003","unstructured":"Stander H, Stadelmann A, Luger T et\u00a0al (2003) Efficacy of fumaric acid ester monotherapy in psoriasis pustulosa palmoplantaris. Br J Dermatol 149:220\u2013222","journal-title":"Br J Dermatol"},{"key":"3804_CR65","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/jdv.12272","volume":"28","author":"R Bissonnette","year":"2014","unstructured":"Bissonnette R, Nigen S, Langley RG et al (2014) Increased expression of IL-17\u202fA and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial. J Eur Acad Dermatol Venereol 28:1298\u20131305","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3804_CR66","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jaad.2011.01.032","volume":"67","author":"A Robinson","year":"2012","unstructured":"Robinson A, Van Voorhees AS, Hsu S et\u00a0al (2012) Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation. J\u00a0Am Acad Dermatol 67:279\u2013288","journal-title":"J Am Acad Dermatol"},{"key":"3804_CR67","first-page":"940","volume":"7","author":"R Bissonnette","year":"2008","unstructured":"Bissonnette R, Poulin Y, Bolduc C et\u00a0al (2008) Etanercept in the treatment of palmoplantar pustulosis. J\u00a0Drugs Dermatol 7:940\u2013946","journal-title":"J Drugs Dermatol"},{"key":"3804_CR68","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/09546634.2012.672710","volume":"24","author":"SC Au","year":"2013","unstructured":"Au SC, Goldminz AM, Kim N et al (2013) Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis. J Dermatolog Treat 24:179\u2013187","journal-title":"J Dermatolog Treat"},{"key":"3804_CR69","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gutjnl-2012-302853","volume":"63","author":"C Tillack","year":"2014","unstructured":"Tillack C, Ehmann LM, Friedrich M et al (2014) Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-gamma-expressing Th1 cells and IL-17\u202fA\/IL-22-expressing Th17 cells and respond to anti-IL-12\/IL-23 antibody treatment. Gut 63:567\u2013577","journal-title":"Gut"},{"key":"3804_CR70","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1699-258X(08)71810-2","volume":"4","author":"B Perez-Zafrilla","year":"2008","unstructured":"Perez-Zafrilla B, Angel DM, Carmona L (2008) Adverse reactions related to the administration of TNF inhibitors. analysis of a registry of biologic therapy. Reumatol Clin 4:90\u201395","journal-title":"Reumatol Clin"},{"key":"3804_CR71","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ad.2013.05.007","volume":"105","author":"R Navarro","year":"2014","unstructured":"Navarro R, Dauden E (2014) Clinical management of paradoxical psoriasiform reactions during TNF- alpha therapy. Actas Dermosifiliogr 105:752\u2013761","journal-title":"Actas Dermosifiliogr"},{"key":"3804_CR72","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semarthrit.2010.04.003","volume":"40","author":"AN Collamer","year":"2010","unstructured":"Collamer AN, Battafarano DF (2010) Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis. Semin Arthritis Rheum 40:233\u2013240","journal-title":"Semin Arthritis Rheum"},{"key":"3804_CR73","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.jaad.2011.05.038","volume":"67","author":"E Shmidt","year":"2012","unstructured":"Shmidt E, Wetter DA, Ferguson SB et al (2012) Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-alpha inhibitors: the Mayo Clinic experience, 1998 to 2010. J Am Acad Dermatol 67:e179\u2013e185","journal-title":"J Am Acad Dermatol"},{"key":"3804_CR74","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","volume":"102","author":"AK Palucka","year":"2005","unstructured":"Palucka AK, Blanck JP, Bennett L et al (2005) Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci USA 102:3372\u20133377","journal-title":"Proc Natl Acad Sci USA"},{"key":"3804_CR75","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","volume":"202","author":"FO Nestle","year":"2005","unstructured":"Nestle FO, Conrad C, Tun-Kyi A et al (2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 202:135\u2013143","journal-title":"J Exp Med"},{"key":"3804_CR76","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1097\/MIB.0000000000000198","volume":"20","author":"M Friedrich","year":"2014","unstructured":"Friedrich M, Tillack C, Wollenberg A et al (2014) IL-36gamma sustains a proinflammatory self-amplifying loop with\u00a0IL-17\u202fC in anti-TNF-induced psoriasiform skin lesions of patients with Crohn\u2019s disease. Inflamm Bowel Dis 20:1891\u20131901","journal-title":"Inflamm Bowel Dis"},{"key":"3804_CR77","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.crohns.2012.08.007","volume":"7","author":"R Denadai","year":"2013","unstructured":"Denadai R, Teixeira FV, Steinwurz F et al (2013) Induction or exacerbation of psoriatic lesions during anti-TNF-alpha therapy for inflammatory bowel disease: a systematic literature review based on 222 cases. J Crohns Colitis 7:517\u2013524","journal-title":"J Crohns Colitis"},{"key":"3804_CR78","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1684\/ejd.2011.1164","volume":"21","author":"S Gregoriou","year":"2011","unstructured":"Gregoriou S, Kazakos C, Christofidou E et\u00a0al (2011) Pustular psoriasis development after initial ustekinumab administration in chronic plaque psoriasis. Eur J Dermatol 21:104\u2013105","journal-title":"Eur J Dermatol"},{"key":"3804_CR79","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/09546634.2010.534430","volume":"23","author":"KS Wenk","year":"2012","unstructured":"Wenk KS, Claros JM, Ehrlich A (2012) Flare of pustular psoriasis after initiating ustekinumab therapy. J\u00a0Dermatolog Treat 23:212\u2013214","journal-title":"J Dermatolog Treat"},{"key":"3804_CR80","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/ced.12392","volume":"39","author":"RA Hay","year":"2014","unstructured":"Hay RA, Pan JY (2014) Paradoxical flare of pustular psoriasis triggered by ustekinumab, which responded to adalimumab therapy. Clin Exp Dermatol 39:751\u2013752","journal-title":"Clin Exp Dermatol"},{"key":"3804_CR81","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/archdermatol.2011.120","volume":"147","author":"L Laino","year":"2011","unstructured":"Laino L, DiCarlo A (2011) Palmoplantar pustular psoriasis: clinical and video thermographic evaluation before and after topical tacrolimus treatment. Arch Dermatol 147:760","journal-title":"Arch Dermatol"},{"key":"3804_CR82","first-page":"758","volume":"20","author":"K Hayama","year":"2010","unstructured":"Hayama K, Inadomi T, Fujisawa D et al (2010) A pilot study of medium-dose cyclosporine for the treatment of palmoplantar pustulosis complicated with pustulotic arthro-osteitis. Eur J Dermatol 20:758\u2013762","journal-title":"Eur J Dermatol"},{"key":"3804_CR83","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2340\/00015555-0361","volume":"88","author":"G Wozel","year":"2008","unstructured":"Wozel G, Vitez L (2008) Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab. Acta Derm Venereol 88:169\u2013170","journal-title":"Acta Derm Venereol"},{"key":"3804_CR84","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/bjd.12150","volume":"168","author":"C Morales-Munera","year":"2013","unstructured":"Morales-Munera C, Vilarrasa E, Puig L (2013) Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis. Br J Dermatol 168:820\u2013824","journal-title":"Br J Dermatol"},{"key":"3804_CR85","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1365-2133.2010.09897.x","volume":"163","author":"S Gerdes","year":"2010","unstructured":"Gerdes S, Franke J, Domm S et\u00a0al (2010) Ustekinumab in the treatment of palmoplantar pustulosis. Br J Dermatol 163:1116\u20131118","journal-title":"Br J Dermatol"},{"key":"3804_CR86","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1111\/ijd.12511","volume":"53","author":"T Bertelsen","year":"2014","unstructured":"Bertelsen T, Kragballe K, Johansen C et\u00a0al (2014) Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis. Int\u00a0J\u00a0Dermatol 53:e464\u2013e466","journal-title":"Int J Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3804-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-016-3804-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3804-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T06:46:22Z","timestamp":1718606782000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-016-3804-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,30]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3804"],"URL":"https:\/\/doi.org\/10.1007\/s00105-016-3804-4","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,30]]}}}